| Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers L Almeida, M Vaz‐da‐Silva, A Falcão, E Soares, R Costa, AI Loureiro, ... Molecular nutrition & food research 53 (S1), S7-S15, 2009 | 550 | 2009 |
| Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024 AF Ambrósio, P Soares-da-Silva, CM Carvalho, AP Carvalho Neurochemical research 27, 121-130, 2002 | 412 | 2002 |
| Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: a randomized, double‐blind, placebo‐controlled … C Elger, P Halász, J Maia, L Almeida, P Soares‐da‐Silva, ... Epilepsia 50 (3), 454-463, 2009 | 315 | 2009 |
| Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial JJ Ferreira, A Lees, JF Rocha, W Poewe, O Rascol, P Soares-da-Silva The Lancet Neurology 15 (2), 154-165, 2016 | 286 | 2016 |
| Catechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease MJ Bonifácio, PN Palma, L Almeida, P Soares‐da‐Silva CNS drug reviews 13 (3), 352-379, 2007 | 284 | 2007 |
| Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide Derivatives J Benes, A Parada, AA Figueiredo, PC Alves, AP Freitas, DA Learmonth, ... Journal of Medicinal Chemistry 42 (14), 2582-2587, 1999 | 281 | 1999 |
| Eslicarbazepine acetate (BIA 2-093) L Almeida, P Soares-da-Silva Neurotherapeutics 4, 88-96, 2007 | 236 | 2007 |
| Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy E Ben-Menachem, AA Gabbai, A Hufnagel, J Maia, L Almeida, ... Epilepsy Research 89 (2-3), 278-285, 2010 | 231 | 2010 |
| Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase LE Kiss, HS Ferreira, L Torrão, MJ Bonifácio, PN Palma, ... Journal of medicinal chemistry 53 (8), 3396-3411, 2010 | 216 | 2010 |
| Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures A Gil‐Nagel, J Lopes‐Lima, L Almeida, J Maia, P Soares‐da‐Silva, ... Acta Neurologica Scandinavica 120 (5), 281-287, 2009 | 199 | 2009 |
| Opicapone as adjunct to levodopa therapy in patients with Parkinson disease and motor fluctuations: a randomized clinical trial AJ Lees, J Ferreira, O Rascol, W Poewe, JF Rocha, M McCrory, ... JAMA neurology 74 (2), 197-206, 2017 | 189 | 2017 |
| Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive TR Hollon, MJ Bek, JE Lachowicz, MA Ariano, E Mezey, ... Journal of Neuroscience 22 (24), 10801-10810, 2002 | 182 | 2002 |
| Pharmacokinetics and drug interactions of eslicarbazepine acetate M Bialer, P Soares‐da‐Silva Epilepsia 53 (6), 935-946, 2012 | 177 | 2012 |
| Eslicarbazepine acetate: a double‐blind, add‐on, placebo‐controlled exploratory trial in adult patients with partial‐onset seizures C Elger, M Bialer, JA Cramer, J Maia, L Almeida, P Soares‐da‐Silva Epilepsia 48 (3), 497-504, 2007 | 162 | 2007 |
| Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide S Hebeisen, N Pires, AI Loureiro, MJ Bonifácio, N Palma, A Whyment, ... Neuropharmacology 89, 122-135, 2015 | 144 | 2015 |
| Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats N Rebola, JE Coelho, AR Costenla, LV Lopes, A Parada, CR Oliveira, ... European Journal of Neuroscience 18 (4), 820-828, 2003 | 143 | 2003 |
| Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation PA Jose, P Soares-da-Silva, GM Eisner, RA Felder Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 (12 …, 2010 | 137 | 2010 |
| Effect of food on the pharmacokinetic profile of trans-resveratrol M Vaz-da-Silva, AI Loureiro, A Falcao, T Nunes, JF Rocha, ... Int J Clin Pharmacol Ther 46 (11), 564-70, 2008 | 136 | 2008 |
| Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects T Nunes, L Almeida, JF Rocha, A Falcão, C Fernandes‐Lopes, ... The Journal of Clinical Pharmacology 49 (12), 1477-1482, 2009 | 130 | 2009 |
| Interaction of the novel anticonvulsant, BIA 2‐093, with voltage‐gated sodium channels: comparison with carbamazepine MJ Bonifacio, RD Sheridan, A Parada, RA Cunha, L Patmore, ... Epilepsia 42 (5), 600-608, 2001 | 127 | 2001 |
